Portal Vein Thrombosis and Budd-Chiari Syndrome

Clinics in Liver Disease

Volumn 13, Issue 1, 2009, Pages 127-144

  Bittencourt, Paulo Lisboa ^a   Couto, Cláudia Alves ^b   Ribeiro, Daniel Dias ^b  

^a Portuguese Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Budd Chiari syndrome; Cirrhosis; Portal hypertension; Portal vein thrombosis; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

ANGIOPLASTY; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; APPENDICITIS; ASCITES; BLEEDING; BLOOD CLOT LYSIS; BONE MARROW BIOPSY; BUDD CHIARI SYNDROME; CHILDHOOD DISEASE; CHOLECYSTECTOMY; CHOLECYSTITIS; CHRONIC LIVER DISEASE; COLON RESECTION; CROHN DISEASE; CYTOMEGALOVIRUS; DEEP VEIN THROMBOSIS; DIVERTICULITIS; DOPPLER ECHOGRAPHY; ENDOSCOPIC THERAPY; ERYTHROCYTE; FLOW CYTOMETRY; GASTRECTOMY; GENE MUTATION; HEPATITIS; HUMAN; HYPERHOMOCYSTEINEMIA; LIVER ABSCESS; LIVER CYST; LIVER TRANSPLANTATION; LYMPHADENITIS; MYELOPROLIFERATIVE DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OMPHALITIS; ORAL CONTRACEPTION; PANCREATITIS; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PREGNANCY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SCLEROTHERAPY; SECONDARY PREVENTION; SPLENECTOMY; THROMBECTOMY; THROMBOPHILIA; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; ULCERATIVE COLITIS; VARICOSIS;

BUDD-CHIARI SYNDROME; HUMANS; LIVER CIRRHOSIS; PORTAL VEIN; RISK FACTORS; VENOUS THROMBOSIS;

EID: 58149334867     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.10.002     Document Type: Review

References (85)

1. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
2. Valla D.C. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 38 (2003) 793-803
3. Condat B., and Valla D. Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 505-515
4. Middeldorp S., and Levi M. Thrombophilia: an update. Semin Thromb Hemost 33 (2007) 563-572
5. Simioni P., Tormene D., Spiezia L., et al. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost 32 (2006) 700-708
6. Franco R.F., Trip M.P., and Reitsma P.H. Genetic variations of the hemostatic system as a risk factor for venous and arterial thrombotic disease. Curr Genomics 4 (2003) 1-21
7. Janssen H.L., Garcia-Pagan J.C., Elias E., et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38 (2003) 364-371
8. Primignani M., Martinelli I., Bucciarelli P., et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41 (2005) 603-608
9. Denninger M.H., Chait Y., Casadevall N., et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31 (2000) 587-591
10. Janssen H.L., Meinardi J.R., Vleggaar F.P., et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 96 (2000) 2364-2368
11. Bhattacharyya M., Makharia G., Kannan M., et al. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 121 (2004) 844-847
12. Mohanty D., Shetty S., Ghosh K., et al. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from western India. Hepatology 34 (2001) 666-670
13. Brie J.B. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management. Semin Thromb Hemost 32 (2006) 208-218
14. Deltenre P., Denninger M.H., Hillaire S., et al. Factor V Leiden related Budd-Chiari syndrome. Gut 48 (2001) 264-268
15. Aydinli M., and Bayraktar Y. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol 13 (2007) 2693-2696
16. Li X.M., Wei Y.F., Hao H.L., et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol 71 (2002) 11-14
17. Lim W., and Crowther M.A. Antiphospholipid antibodies: a critical review of the literature. Curr Opin Hematol 14 (2007) 494-499
18. Cohn D.M., Roshani S., and Middeldorp S. Thrombophilia and venous thromboembolism: implications for testing. Semin Thromb Hemost 33 (2007) 573-581
19. Sharma S., Kumar S.I., Poddar U., et al. Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India. Indian J Gastroenterol 25 (2006) 236-239
20. Valla D.C. Portal vein thrombosis and prothrombotic disorders. J Gastroenterol Hepatol 14 (1999) 1051-1052
21. Valla D.C. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 19 (2004) S204-S211
22. Heit J.A. Thrombophilia: common questions on laboratory assessment and management. Educational Book. Hematology (2007) 127-135
23. Chait Y., Condat B., Cazals-Hatem D., et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 129 (2005) 553-560
24. Patel R.K., Nicholas C.L., Heneghan M.A., et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 130 (2006) 2031-2038
25. Thurmes P.J., and Steensma D.P. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis. Eur J Haematol 77 (2006) 57-60
26. Colaizzo D., Amitrano L., Tiscia G.L., et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost 5 (2007) 55-61
27. Jones A.V., Kreil S., Zoi K., et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106 (2005) 2162-2168
28. De Stefano V., Fiorini A., Rossi E., et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 5 (2007) 708-714
29. Kaushansky K. On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 105 (2005) 4258-4263
30. Dudley J.M., Westwood N., Leonard S., et al. Primary polycythemia: positive diagnosis using the differential response of primitive and mature erythroid progenitors to erythropoietin, interleukin 3 and alpha-interferon. Br J Haematol 75 (1990) 188-194
31. Dainiak N., Hoffman R., Lebowitz A.I., et al. Erythropoietin-dependent primary pure erythrocytosis. Blood 53 (1979) 1076-1084
32. Eridani S., Dudley J.M., Sawyer B.M., et al. Erythropoietic colonies in a serum-free system: results in primary proliferative polycythemia and thrombocythemias. Br J Haematol 67 (1987) 387-391
33. Levine R.L., and Wernig G. Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders. Hematology Am Soc Hematol Educ Program 510 (2006) 233-239
34. Kralovics R., Passamonti F., Buser A.S., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
35. Kiladjian J.J., Cervantes F., Leebeek F.W., et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 111 (2008) 4922-4929
36. Murad S.D., Plessier A., Hernandez Guerra M., et al. A prospective follow-up study on 163 patients with Budd-Chiari syndrome: results from the European network for vascular disorders of the liver (EM_VIE). J Hepatol 46 (2007) S4 [abstract]
37. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 (2002) 752-763
38. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 296-306
39. Superina R., Bambini D.A., Lokar J., et al. Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass. Ann Surg 243 (2006) 515-521
40. Ziakas P.D., Poulou L.S., Rokas G.I., et al. Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5 (2007) 642-645
41. Sarin S.K., Sollano J.D., Chawla Y.K., et al. Consensus on extra-hepatic portal vein obstruction. Liver Int 26 (2006) 512-519
42. Ogren M., Bergqvist D., Bjorck M., et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 12 (2006) 2115-2119
43. Pinto R.B., Silveira T.R., Bandinelli E., et al. Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. J Pediatr Surg 39 (2004) 1356-1361
44. Pugliese R.P.S., Porta G., D'Amico E.A., et al. Risk factors in children and adolescents with portal vein thrombosis (PVT) and portal hypertension. Hepatology 28 (1998) 551A
45. Alvarez F. Risk of portal obstruction in newborns. J Pediatr 148 (2006) 715-716
46. El-Karaksy H., El-Koofy N., El-Hawary M., et al. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann Hematol 83 (2004) 712-715
47. Lykavieris P., Gauthier F., Hadchouel P., et al. Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. J Pediatr 136 (2000) 805-808
48. Alvarez F., Bernard O., Brunelle F., et al. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediat 103 (1983) 696-702
49. Rangari M., Gupta R., Jain M., et al. Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int 23 (2003) 434-439
50. De Ville de Goyet J., Gibbs P., Clapuyt P., et al. Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long-term results. Transplantation 62 (1996) 71-75
51. Superina R., Shneider B., Emre S., et al. Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant 10 (2006) 908-913
52. Murad S.D., Valla D.C., de Groen P.C., et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 101 (2006) 83-90
53. Janssen H.L., Wijnhourd A., Haagsma E.B., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49 (2001) 720-724
54. Mínguez B., García-Pagán J.C., Bosch J., et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 43 (2006) 707-714
55. Condat B., Pessione F., Hillaire S., et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32 (2000) 466-470
56. Condat B., Pessione F., Hillaire S., et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120 (2001) 490-497
57. Plessier A., Murad S.D., Hernandez Guerra M., et al. A prospective multicentric follow-up study on 105 patients with acute portal vein thrombosis (PVT): results from the European network for vascular disorders of the liver (EM-VIE). Hepatology 46 (2007) 309A [abstract]
58. Hollingshead M., Burke C.T., Mauro M.A., et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 651-661
59. Senzolo M., Tibbals J., Cholongitas E., et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 23 (2006) 767-775
60. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40 (2004) 736-741
61. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54 (2006) 691-697
62. Amitrano L., Brancaccio V., Guardascione M.A., et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31 (2000) 345-348
63. Yerdel M.A., Gunson B., Mirza D., et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69 (2000) 1873-1881
64. Ludwig J., Hashimoto E., McGill D.B., et al. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 65 (1990) 51-55
65. Murad S.D., Valla D.C., de Groen P.C., et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 39 (2004) 500-508
66. Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol 16 (2001) 1179-1183
67. Zimmerman M.A., Cameron A.M., and Ghobrial R.M. Budd-Chiari syndrome. Clin Liver Dis 10 (2006) 259-273
68. Menon K.V.N., Shah V., and Kamath P.S. Current concepts: the Budd-Chiari Syndrome. N Engl J Med 350 (2004) 578-585
69. Hadengue A., Poliquin M., Vilgrain V., et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106 (1994) 1042-1047
70. Dilawari J.B., Bambery P., Chawla Y., et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 73 (1994) 21-36
71. Mahmoud A.E., Mendoza A., Meshikhes A.N., et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. Q J Med 89 (1996) 37-43
72. Bolondi L., Gaiani S., Li Bassi S., et al. Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology 100 (1991) 1324-1331
73. DeLeve L.D., Shulman H.M., and McDonald G.B. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22 (2002) 27-42
74. Kamath P. Budd-Chiari syndrome: radiologic findings. Liver Transp 12 (2006) S21-S22
75. Chawla Y., Kumar S., Dhiman R.K., et al. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 14 (1999) 904-907
76. Brancatelli G., Vilgrain V., Federle M.P., et al. Budd-Chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol 188 2 (2007) 168-176
77. Langlet P., Escolano S., Valla D., et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 39 (2003) 496-501
78. Zeitoun G., Escolano S., Hadengue A., et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 30 (1999) 84-89
79. Orloff M.J., Daily P.O., Orloff S.L., et al. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 232 (2000) 340-352
80. Klein A.S. Management of Budd-Chiari syndrome. Liver Transpl 12 (2006) S23-S28
81. Eapen C.E., Velissaris D., Heydtmann M., et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 55 (2006) 878-884
82. Mentha G., Giostra E., Majno P.E., et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 44 (2006) 520-528
83. Cruz E., Ascher N.L., Roberts J.P., et al. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant 19 (2005) 501-506
84. Sarin S.K., and Kumar A. Non-cirrhotic portal hypertension. Clin Liver Dis 10 (2006) 627-651
85. Hillaire S., Bonte E., Denninger M.-H., et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the west: a re-evaluation in 28 patients. Gut 51 (2002) 275-280